Johns Hopkins University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count).
Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.
Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.
Top-decile sponsor footprint
Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
943 of 1,108 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,448 total, page 10 of 29
Long-term Impact in Intensive Care Survivors of Coronavirus Disease (COVID-19)
NCT05175339
Pilot Testing A Theory-Driven Self-Management Intervention for Chronic Musculoskeletal Pain
NCT05020470
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
NCT05038982
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
NCT04147052
Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
NCT05038371
Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS
NCT04749433
Cigarette Smoking Decision Study
NCT04595279
Ending the HIV Epidemic Through Point-of-Care Technologies (EHPOC)
NCT04793750
The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions
NCT04283019
Rapid HCV Treatment Access for Persons Who Use Drugs
NCT04677153
Art Museum Program for Seniors With Cognitive Disorders and Care-partners
NCT04696549
The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
NCT04741477
Cognitive Assessment in COVID-19 Positive Patients Using the DANA App
NCT05143333
COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV
NCT04958889
Aligning Medications With What Matters Most
NCT04938648
Dietary Approaches to Stop Hypertension for Diabetes
NCT04286555
Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse
NCT04195776
Penicillin Allergy Testing in STD Clinics
NCT04620746
Virtual Patient Education From Real Cases
NCT04553640
Pelvic Floor Disorder Assessment of Knowledge and Symptoms: an Educational Model in Spanish-Speaking Women
NCT04829721
Acceptability, Feasibility and Preliminary Efficacy of CFWP to Treat Clinically Elevated Fatigue in Adults With CF
NCT04809207
Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections
NCT04884308
Transforming Robot-mediated Telerehabilitation: Citizen Science for Rehabilitation
NCT03096262
Enteric Neural Precursor Cells (ENPC) in the Human Gut
NCT04880538
Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and Treatment
NCT04859829
Non-invasive Vagal Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients With Gastroparesis and Related Disorders
NCT04857281
Impact of Nursing Involvement on Implementation of HIV Prevention Services
NCT05095818
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
NCT01448915
Cuff(SZ): The Cuff Size Blood Pressure Measurement Trial
NCT04610775
Environmental Localization Mapping and Guidance for Visual Prosthesis Users
NCT04359108
Adapting an Evidenced-based Weight Management Intervention and Testing Strategies to Increase Implementation in Community Mental Health Programs
NCT03454997
Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye
NCT04498468
Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity
NCT04724330
Intra-operative Uterosacral Ligament Bupivacaine Injection During Minimally Invasive Hysterectomy
NCT04157075
Promoting Evidenced-Based Tobacco Smoking Cessation Treatment in Community Mental Health Clinics
NCT04796961
Families Talking Together Plus: An Approach to Promote Sexual Delay and Strengthen Sexual Risk Avoidance Education
NCT04731649
Improving Communication for Primary Care Patients
NCT04819191
Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW
NCT04760691
A Quality Improvement Process to Support Delivery of Cardiovascular Care in Community Mental Health Organizations
NCT04696653
The Use of Eculizumab in HELLP Syndrome
NCT04103489
Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis
NCT04054050
Peri-Atrial Inflammatory Fat and Atrial Fibrillation
NCT04186169
Pleural Manometry for the Characterization of Spontaneous and Tension Pneumothorax
NCT04630301
Community Collaboration to Combat COVID-19 (C-FORWARD)
NCT04673292
COVID-19 Preventive Behavior in African Americans
NCT04700462
A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain
NCT04504812
Lidocaine Patch for Neck Pain
NCT04378959
CGM Use in Poorly Controlled Youth With Type 1 Diabetes
NCT04721145
Pilot Study of Video and Telephone Primary Care Visits
NCT04496713
CGM Use in Children With Type 2 Diabetes
NCT04721158
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 201 |
| Phase 2 | 198 |
| Phase 3 | 44 |
| Phase 4 | 81 |
Therapeutic Areas
What is open in the Johns Hopkins University pipeline
250 recruiting of 1,448 indexed (17% open); 943 completed (65%).
Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).
Top condition: Hypertension (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Johns Hopkins University: open-pipeline peers nationwide
Peers matched on 1,448 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Johns Hopkins University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,448 trials (± recruiting share)
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Yale University · 1,492 trials · 17% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Seattle Children's Hospital · 17% recruiting · 168 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
- Virginia Polytechnic Institute and State University · 17% recruiting · 104 trials
Related
What to do with this Johns Hopkins University page
1,448 registered trials is a research-attention snapshot, not an endorsement of Johns Hopkins University or any single study.
- 250 of Johns Hopkins University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Johns Hopkins University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Johns Hopkins University pipeline card: 1,448 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.